COVID-19 reinfection: prolonged shedding or true reinfection?

被引：37

作者：

Falahi, S. ^{[1
]}

Kenarkoohi, A. ^{[2
]}

机构：

[1] Ilam Univ Med Sci, Zoonot Dis Res Ctr, Ilam, Iran

[2] Ilam Univ Med Sci, Dept Microbiol, Fac Med, Ilam, Iran

来源：

NEW MICROBES AND NEW INFECTIONS | 2020年 / 38卷

关键词：

COVID-19; positive re-test; prolonged shedding; SARS-CoV-2; true reinfection;

D O I：

10.1016/j.nmni.2020.100812

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

The SARS-CoV-2 pandemic is underway and millions of people have been infected. A large number of patients with COVID-19 have recovered and been discharged. While a number of recovered patients test positive again or even have a recurrence of clinical symptoms. Some researchers believe that a positive retest is related to the long-term persistence of the virus in the body, although there is some evidence in favor of reinfection. In this study, we focus more on the possible reasons for positive retesting, antibody responses, and review of possible reinfection case reports. (C) 2020 The Author(s). Published by Elsevier Ltd.

引用

页数：4

共 22 条

[1] [Anonymous], 2020, J MED VIROL, DOI DOI 10.1002/jmv.26241
[2] [Anonymous], 2020, CLIN INFECT DIS, DOI DOI 10.1093/cid/ciaa149
[3] Bao L, 2020, bioRxiv, DOI 10.1101/2020.03.13.990226
[4] SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis
Cevik, Muge
Tate, Matthew
Lloyd, Ollie
Maraolo, Alberto Enrico
Schafers, Jenna
Ho, Antonia
[J]. LANCET MICROBE, 2021, 2 (01): : E13 - E22
[5] Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19
Chen, Xiangyu
Pan, Zhiwei
Yue, Shuai
Yu, Fei
Zhang, Junsong
Yang, Yang
Li, Ren
Liu, Bingfeng
Yang, Xiaofan
Gao, Leiqiong
Li, Zhirong
Lin, Yao
Huang, Qizhao
Xu, Lifan
Tang, Jianfang
Hu, Li
Zhao, Jing
Liu, Pinghuang
Zhang, Guozhong
Chen, Yaokai
Deng, Kai
Ye, Lilin
[J]. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
[6] European Centre for Disease Prevention and Control, 2020, REINF SARS COV CONS
[7] Goldman Jason D, 2020, medRxiv, DOI 10.1101/2020.09.22.20192443
[8] Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?
Gousseff, Marie
Penot, Pauline
Gallay, Laure
Batisse, Dominique
Benech, Nicolas
Bouiller, Kevin
Collarino, Rocco
Conrad, Anne
Slama, Dorsaf
Joseph, Cedric
Lemaignen, Adrien
Lescure, Francois-Xavier
Levy, Bruno
Mahevas, Matthieu
Pozzetto, Bruno
Vignier, Nicolas
Wyplosz, Benjamin
Salmon, Dominique
Goehringer, Francois
Botelho-Nevers, Elisabeth
[J]. JOURNAL OF INFECTION, 2020, 81 (05) : 821 - 825
[9] Asymptomatic Reinfection in 2 Healthcare Workers From India With Genetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2
Gupta, Vivek
Bhoyar, Rahul C.
Jain, Abhinav
Srivastava, Saurabh
Upadhayay, Rashmi
Imran, Mohamed
Jolly, Bani
Divakar, Mohit Kumar
Sharma, Disha
Sehgal, Paras
Ranjan, Gyan
Gupta, Rakesh
Scaria, Vinod
Sivasubbu, Sridhar
[J]. CLINICAL INFECTIOUS DISEASES, 2021, 73 (09) : E2823 - E2825
[10] Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients
Iyer, Anita S.
Jones, Forrest K.
Nodoushani, Ariana
Kelly, Meagan
Becker, Margaret
Slater, Damien
Mills, Rachel
Teng, Erica
Kamruzzaman, Mohammad
Garcia-Beltran, Wilfredo F.
Astudillo, Michael
Yang, Diane
Miller, Tyler E.
Oliver, Elizabeth
Fischinger, Stephanie
Atyeo, Caroline
Iafrate, A. John
Calderwood, Stephen B.
Lauer, Stephen A.
Yu, Jingyou
Li, Zhenfeng
Feldman, Jared
Hauser, Blake M.
Caradonna, Timothy M.
Branda, John A.
Turbett, Sarah E.
Larocque, Regina C.
Mellon, Guillaume
Barouch, Dan H.
Schmidt, Aaron G.
Azman, Andrew S.
Alter, Galit
Ryan, Edward T.
Harris, Jason B.
Charles, Richelle C.
[J]. SCIENCE IMMUNOLOGY, 2020, 5 (52)

← 1 2 3 →